Aptamer Group plc Logo

Aptamer Group plc

APTA.L

(1.0)
Stock Price

0,29 GBp

-181.21% ROA

-222.17% ROE

-0.11x PER

Market Cap.

4.224.756,00 GBp

21.41% DER

0% Yield

-677.39% NPM

Aptamer Group plc Stock Analysis

Aptamer Group plc Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Aptamer Group plc Fundamental Stock Analysis
# Analysis Rating
1 PBV

With a remarkably low PBV ratio (0.1x), the stock offers substantial upside potential at a bargain price.

2 DER

The stock has a minimal amount of debt (16%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 ROE

The stock's ROE indicates a negative return (-50.45%) on shareholders' equity, suggesting poor financial performance.

4 ROA

The stock's ROA (-18.72%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Aptamer Group plc Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Aptamer Group plc Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Aptamer Group plc Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Aptamer Group plc Revenue
Year Revenue Growth
2018 986.661
2019 854.568 -15.46%
2020 1.280.000 33.24%
2021 4.036.000 68.29%
2022 1.752.000 -130.37%
2023 596.000 -193.96%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Aptamer Group plc Research and Development Expenses
Year Research and Development Expenses Growth
2018 63.081
2019 170.459 62.99%
2020 491.200 65.3%
2021 848.000 42.08%
2022 474.000 -78.9%
2023 340.000 -39.41%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Aptamer Group plc General and Administrative Expenses
Year General and Administrative Expenses Growth
2018 1.033.562
2019 1.174.873 12.03%
2020 2.500.800 53.02%
2021 4.352.000 42.54%
2022 5.034.000 13.55%
2023 3.470.000 -45.07%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Aptamer Group plc EBITDA
Year EBITDA Growth
2018 -382.667
2019 -733.590 47.84%
2020 -2.237.600 67.22%
2021 -2.137.000 -4.71%
2022 -4.763.000 55.13%
2023 -3.588.000 -32.75%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Aptamer Group plc Gross Profit
Year Gross Profit Growth
2018 612.852
2019 455.970 -34.41%
2020 538.400 15.31%
2021 2.685.000 79.95%
2022 359.000 -647.91%
2023 -52.000 790.38%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Aptamer Group plc Net Profit
Year Net Profit Growth
2018 -454.984
2019 -674.730 32.57%
2020 -1.849.600 63.52%
2021 -2.093.000 11.63%
2022 -7.836.000 73.29%
2023 -3.614.000 -116.82%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Aptamer Group plc Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2018 0
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Aptamer Group plc Free Cashflow
Year Free Cashflow Growth
2018 -885.753
2019 -243.540 -263.7%
2020 -1.256.800 80.62%
2021 -2.793.000 55%
2022 -6.092.000 54.15%
2023 -881.500 -591.09%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Aptamer Group plc Operating Cashflow
Year Operating Cashflow Growth
2018 -844.933
2019 -82.712 -921.54%
2020 -1.099.200 92.48%
2021 -2.375.000 53.72%
2022 -4.064.000 41.56%
2023 -878.500 -362.61%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Aptamer Group plc Capital Expenditure
Year Capital Expenditure Growth
2018 40.820
2019 160.828 74.62%
2020 157.600 -2.05%
2021 418.000 62.3%
2022 2.028.000 79.39%
2023 3.000 -67500%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Aptamer Group plc Equity
Year Equity Growth
2018 899.871
2019 245.806 -266.09%
2020 105.000 -134.1%
2021 8.051.000 98.7%
2022 304.000 -2548.36%
2023 1.990.000 84.72%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Aptamer Group plc Assets
Year Assets Growth
2018 1.397.126
2019 1.389.770 -0.53%
2020 2.064.000 32.67%
2021 11.520.000 82.08%
2022 2.753.000 -318.45%
2023 3.968.000 30.62%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Aptamer Group plc Liabilities
Year Liabilities Growth
2018 497.255
2019 1.143.964 56.53%
2020 1.959.000 41.6%
2021 3.469.000 43.53%
2022 2.449.000 -41.65%
2023 1.978.000 -23.81%

Aptamer Group plc Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0.02
Price to Earning Ratio
-0.11x
Price To Sales Ratio
4.08x
POCF Ratio
-0.26
PFCF Ratio
-1.29
Price to Book Ratio
0.4
EV to Sales
3.41
EV Over EBITDA
-0.88
EV to Operating CashFlow
-1.17
EV to FreeCashFlow
-1.07
Earnings Yield
-8.87
FreeCashFlow Yield
-0.78
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.05
Graham NetNet
0

Income Statement Metrics

Net Income per Share
-0.02
Income Quality
0.43
ROE
-2.22
Return On Assets
-1.77
Return On Capital Employed
-1.69
Net Income per EBT
0.97
EBT Per Ebit
1.6
Ebit per Revenue
-4.37
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
2.68
Research & Developement to Revenue
0.24
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
-0.55
Operating Profit Margin
-4.37
Pretax Profit Margin
-6.99
Net Profit Margin
-6.77

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.01
Free CashFlow per Share
-0.01
Capex to Operating CashFlow
-0.09
Capex to Revenue
0.26
Capex to Depreciation
0.48
Return on Invested Capital
-1.86
Return on Tangible Assets
-1.81
Days Sales Outstanding
250.74
Days Payables Outstanding
65.11
Days of Inventory on Hand
29.94
Receivables Turnover
1.46
Payables Turnover
5.61
Inventory Turnover
12.19
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,01
Tangible Book Value per Share
0.01
Shareholders Equity per Share
0.01
Interest Debt per Share
0
Debt to Equity
0.21
Debt to Assets
0.11
Net Debt to EBITDA
0.18
Current Ratio
2.14
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
2301000
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.02
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
132000
Debt to Market Cap
0.1

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Aptamer Group plc Dividends
Year Dividends Growth

Aptamer Group plc Profile

About Aptamer Group plc

Aptamer Group plc provides binders for research, diagnostics, and therapeutics in the United Kingdom and internationally. The company's binders engineered to address issues which founds with molecules, such as antibodies; and offers solutions to bioprocessing, diagnostic, and pharmaceutical scientists. It serves pharma companies, diagnostic development companies, and research institutes. The company was incorporated in 2014 and is based in York, the United Kingdom.

CEO
Dr. Arron Craig Tolley
Employee
37
Address
Bio Centre
York, YO10 5NY

Aptamer Group plc Executives & BODs

Aptamer Group plc Executives & BODs
# Name Age
1 Dr. Arron Craig Tolley
Chief Technical Officer & Director
70
2 Andrew Rapson
Chief Financial Officer & Company Secretary
70
3 Mr. Alastair Fleming
Chief Operating Officer
70
4 Dr. David Bunka
Chief Scientific Officer, Member of the Scientific Advisory Board & Executive Director
70

Aptamer Group plc Competitors

Abingdon Health Plc Logo
Abingdon Health Plc

ABDX.L

(0.5)
Poolbeg Pharma PLC Logo
Poolbeg Pharma PLC

POLB.L

(1.0)